Preclinical Characterization of PRT7732: A Highly Potent, Selective, and Orally Bioavailable Targeted Protein Degrader of SMARCA2

Artem Shvartsbart, Koichi Ito, Joseph Rager, Liang Lu, Michael Hulse, Anjana Agarwal, Komali Vykuntam, Jessica Burtell, Min Wang, Justin Kurian, Miles Cowart, Joy Cote, Nick Stahl, Monisha Sivakumar, Anthony Reichelderfer, Jack Carter, Alex Grego, Carly Bachner, Andrew Moore, Neha Bhagwat, Ross Kuskovsky, Shanthi Ganesan, Stefan Ruepp, Tom Emm, Philip Pitis, Corey Basch, Klare Bersch, Yongchun Pan, Song Mei, Raul Leal, John Rose, Danielle Roth, Chaoyi Xu, Karl Blom, Ganfeng Cao, Kris Vaddi, Sang Hyun Lee, Sandy Geeganage,
Andrew Combs, Peggy Scherle